MB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 delta and omicron variants alter trophoblast cell fusion and syncytiotrophoblast dynamics : new insights into placental vulnerability | Cell death and disease |  | 2025 | 19 | 20 | ||
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | | 2024 | 73 | 118 | ||
| Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses | Biomedicine & pharmacotherapy | | 2023 | 255 | 127 | ||
| SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | | 2023 | 115 | 193 | ||
| Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species | Virus research | | 2023 | 46 | 95 | ||
| Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant | Microbiology spectrum | | 2022 | 270 | 214 | ||
| A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern | Journal of clinical virology | | 2022 | 68 | 163 | ||
| Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study | PloS one | | 2022 | 367 | 95 | ||
| Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | | 2022 | 1,451 | 212 | ||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | | 2022 | 284 | 182 | ||
| SARS-CoV-2 antigen-detecting rapid tests for the delta variant | The Lancet microbe | | 2022 | 312 | 114 | ||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | 2021 | 523 | 320 | ||
| SARS-CoV-2 rapid diagnostic tests for emerging variants | The Lancet. Microbe | | 2021 | 499 | 118 |
